NewAge Industries Bolsters Leadership Team with Key Appointments

NewAge Industries, Inc., a leader in the design, manufacture, and distribution of fluid transfer systems, has announced the appointment of two seasoned professionals to its leadership team. Mark Thornton, MBA, joins as a Board Member, bringing over twenty-five years of experience in the biopharma industry, including his current role as President and CEO of VIO Biosciences. His expertise in global leadership and strategic vision is expected to guide the company in areas such as mergers and acquisitions, global expansion, and new product development.

Rick Chomik, MS, has been appointed to the newly created position of Vice President of Operations. With a background in engineering and operational management, Chomik's leadership is anticipated to enhance the company's operational efficiency and innovation. His previous roles include COO at the ALOE Group and positions at Stress Engineering Services, among others. Mary Marcus, CEO of NewAge Industries, Inc., expressed enthusiasm about the new appointments, highlighting the value of Thornton and Chomik's extensive experience as the company enters its next growth phase.

These strategic hires underscore NewAge Industries' commitment to strengthening its position in the high purity pharmaceutical, biopharma, and industrial markets. The appointments signal a deliberate move to enhance strategic direction and operational excellence as the company prepares for expansion. Thornton's background in biopharma leadership positions him to guide NewAge Industries through potential mergers and acquisitions, while Chomik's operational expertise is expected to drive efficiency and innovation in manufacturing processes.

The timing of these appointments coincides with increasing demand for specialized fluid transfer systems in pharmaceutical and biopharmaceutical applications. By bringing in executives with proven track records in these sectors, NewAge Industries demonstrates its focus on capturing market share in high-growth areas. The company's emphasis on high purity applications reflects broader industry trends toward more stringent quality standards in pharmaceutical manufacturing.

These leadership changes represent more than routine personnel updates; they reflect a strategic repositioning of the company for future challenges and opportunities. The creation of a new Vice President of Operations position indicates an organizational shift toward prioritizing operational optimization. Meanwhile, adding Thornton to the board suggests increased attention to corporate strategy and governance as the company scales its operations.

The implications extend beyond NewAge Industries to the broader fluid transfer systems market, where competition is intensifying as pharmaceutical and industrial applications become more technologically sophisticated. These appointments may signal increased investment in research and development, potentially leading to new product offerings that address evolving customer needs. The moves also suggest confidence in the company's growth trajectory, as such strategic hires typically accompany expansion plans.